cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024 08:00 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Umoja_Biopharma_Logo.png
Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference
November 26, 2024 09:05 ET | Umoja Biopharma, Inc.
SEATTLE, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of...
Umoja_Biopharma_Logo.png
Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors
November 21, 2024 08:05 ET | Umoja Biopharma, Inc.
SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR...
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics to Participate in Upcoming Investor Conferences
November 05, 2024 16:05 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics to Participate in Upcoming Investor Conferences
cargo-logo-full-color-rgb-1165px@300ppi.png
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
November 05, 2024 09:23 ET | Cargo Therapeutics, Inc.
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma
Umoja_Biopharma_Logo.png
Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of Hematology Annual Meeting
November 05, 2024 09:05 ET | Umoja Biopharma, Inc.
SEATTLE, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of...
Umoja_Biopharma_Logo.png
Umoja Biopharma Announces Poster Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer
October 04, 2024 09:05 ET | Umoja Biopharma, Inc.
SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of...
Umoja_Biopharma_Logo.png
Umoja Biopharma Announces Oral Presentation at the American College of Rheumatology Convergence 2024
September 30, 2024 16:30 ET | Umoja Biopharma, Inc.
SEATTLE, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of...
Umoja_Biopharma_Logo.png
Umoja Biopharma to Present at the 9th Annual CAR-TCR Summit
September 11, 2024 16:30 ET | Umoja Biopharma, Inc.
SEATTLE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of...